Cegla J, et al
The choice should be based on metabolic needs, tolerability, and individual clinical factors
Demand For Ozempic, Zepbound And Other GLP-1 Agonists Continues To Increase Despite Prices So, insurance coverage for these medications has gone down while demand for them has continued to go up and up
Tissue distribution favors areas with high GLP-1 and GIP receptor expression: pancreas, gut, brain, and adipose tissue
Additionally, berberines metabolites, such as berberrubine and palmatine, have been demonstrated to significantly enhance GLP-1 production and glucose-stimulated secretion in GLUTag cells, suggesting a complex metabolic interplay involving both the parent compound and its active derivatives (Weili Yang et al., 2024)